Effectiveness of the etonogestrel subdermal implant in users with overweight and obesity: a systematic literature review
Observed implant effectiveness in women with overweight and obesity falls within the range of published data across all weight groups (0.0-1.4/100 WY) and does not suggest a reduced effectiveness associated with higher body mass index. Large, well-controlled studies designed to specifically assess the effectiveness of the ENG implant with respect to user weight, particularly in women following bariatric surgery, are warranted.
Authors
- Clare Barnett (ORCID: https://orcid.org/0000-0001-9236-1396)
- Vanessa Pérez (ORCID: https://orcid.org/0000-0003-0586-3019)
- Moritz Klinghardt (ORCID: https://orcid.org/0000-0002-7139-0427)
- Johannes Bitzer (ORCID: https://orcid.org/0000-0001-7505-0684)
- Sophia von Stockum (ORCID: https://orcid.org/0000-0001-5117-7242)
- John W Grunden
- Daisuke Goto (ORCID: https://orcid.org/0000-0003-4921-3851)
Institutions
- University of Basel (CH)
- Berlin Center for Epidemiology and Health Research (DE)
Publication Details
- Journal
- BMJ Sexual & Reproductive Health
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1136/bmjsrh-2024-202424
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.53